ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Vitamin D supplement use associated with lower risk of breast cancer

Carnitine deficiency suggested as contributor to autism

Hop Oil: A Safe Sleep Aide

Lutein — An Important Nutrient for Eye and Brain Health

White Camphor Oil: The Purest Camphor Oil

Taurine: Facts About This Crucial Amino Acid

 
Print Page
Email Article

Migraine headaches in Chronic Fatigue Syndrome (CFS): Comparison of two prospective cross-sectional studies – Source: BMC Neurology, Mar 5, 2011

  [ 8 votes ]   [ Discuss This Article ]
By Murugan K Ravindran, James N Baraniuk, et al. • www.ProHealth.com • March 5, 2011


[Note: To read the full text of this open access article, click HERE. ]

Background: Headaches are more frequent in Chronic Fatigue Syndrome (CFS) than healthy control (HC) subjects. The 2004 International Headache Society (IHS) criteria were used to define CFS headache types.

Methods:

Subjects in Cohort 1 (HC = 368; CFS = 203) completed questionnaires about many diverse symptoms by giving nominal (yes/no) answers.

Cohort 2 (HC = 21; CFS =67) had more focused evaluations. They scored symptom severities on 0 to 4 anchored ordinal scales, and had structured headache evaluations. All subjects had history and physical examinations; assessments for exclusion criteria; questionnaires about CFS related symptoms (0 to 4 scale), Multidimensional Fatigue Inventory (MFI) and Medical Outcome Survey Short Form 36 (MOS SF-36).

Results:

• Demographics, trends for the number of diffuse "functional" symptoms present, and severity of CFS case designation criteria symptoms were equivalent between CFS subjects in Cohorts 1 and 2.

• HC had significantly fewer symptoms, lower MFI and higher SF-36 domain scores than CFS in both cohorts.

• Migraine headaches were found in 84%, and tension-type headaches in 81% of Cohort 2 CFS.

• This compared to 5% and 45%, respectively, in HC.

The CFS group had:

• Migraine without aura (60%; MO; CFS+MO),

• With aura (24%; CFS+MA),

• Tension headaches only (12%),

• Or no headaches (4%).

• Co-morbid tension and migraine headaches were found in 67% of CFS.

CFS+Migraine without aura (MO) had:

• Higher severity scores than CFS+Migraine with aura (MA) for the sum of scores for poor memory, dizziness, balance, and numbness ("Neuro-construct", p=0.002)

• And perceived heart rhythm disturbances, palpitations and noncardiac chest pain ("Cardio-construct"; p=0.045, t-tests after Bonferroni corrections).

CFS+MO subjects had lower pressure-induced pain thresholds (2.36 kg [1.95-2.78; 95% C.I.] n=40) and a higher prevalence of fibromyalgia (47%; 1990 criteria) compared to HC (5.23% [3.95-6.52] n=20; and 0%, respectively).

Sumatriptan was beneficial for 13 out of 14 newly diagnosed CFS migraine subjects.

Conclusions: CFS subjects had higher prevalences of migraine without aura (MO) and migraine with aura (MA) than healthy controls, suggesting that mechanisms of migraine pathogenesis such as central sensitization may contribute to CFS pathophysiology.

Clinical Trial Registration: Georgetown University IRB # 2006-481, ClinicalTrials.gov NCT00810329.

Source: BMC Neurology, Mar 5, 2011. Ravindran MK, Zheng Y, Timbol C, Merck SJ, Baraniuk JN. Division of Rheumatology, Immunology and Allergy, Georgetown University, Washington, DC, USA. [Email: baraniuj@georgetown.edu





Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Ultra EPA  - Fish Oil Ultra ATP+, Double Strength


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Fatigue & Fibro Fog: Could You Have a B-12 Deficiency? Fatigue & Fibro Fog: Could You Have a B-12 Deficiency?
Inflammation Disrupts Memory - What Can You Do to Protect Your Brain? Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?
Priming Your Immune System for Cold & Flu Season Priming Your Immune System for Cold & Flu Season
Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?
Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map